Newsroom

Abbildung eines Corona-Virus
News
Helmholtz position paper on the epidemiological situation
Researchers from the Helmholtz Centre for Infection Research (HZI) in Braunschweig and the Forschungszentrum Jülich (FZJ) are modelling the further course of the epidemic, taking into account various scenarios for relaxing the ban on contact and making recommendations.
14.04.2020
HZI Campus
Coronavirus
News
"It's too early to ease restrictions"
Scientists from the Helmholtz Centre for Infection Research (HZI) in Braunschweig are simulating the effect of various conditions on the development of the SARS-CoV-2 epidemic in Germany. Their results suggest that the restrictions in social life are effective and that a further slowing of the spread is possible. In order to protect the health system from overload, they urgently warn against easing the restrictions already now. They have published their preliminary results, which have not yet been peer-reviewed, on a preprint server for quick scientific use.
08.04.2020
HZI Campus
Viren
News
Step-by-step Plan for after the Shutdown
An interdisciplinary group of renowned scientists - among them Prof Gérard Krause, head of the Department Epidemiology at the Helmholtz Centre for Infection Research (HZI) in Braunschweig - is now calling for the current restrictions in society and the economy to be gradually eased, while ensuring medical care for the entire population.
04.04.2020
HZI Campus
Die SORMAS-App in der Anwendung.
News
SORMAS supports German health authorities in contact person management
The Covid-19 pandemic affects more and more countries worldwide. Since the virus causes no or only mild symptoms in many infected people, researchers assume that the number of unreported cases is high. In order to slow down the further spread of the virus, health authorities are focusing on consistent management of contact persons of confirmed cases of infection. For this purpose, the German Public Health Service (ÖGD) will be able to use a special version of the SORMAS disease control app in the future.
01.04.2020
HZI Campus
Viruszellen
News
"We are not defenceless against the novel coronavirus"
27.03.2020
HZI Campus
Blutproben
News
Population study investigates immunity to Covid-19
After an infection with the coronavirus SARS-CoV-2, patients have antibodies against the pathogen in their blood. These are retained over a long period of time and are an indication for a past infection. It is assumed that patients who have recovered from the Covid-19 disease cannot be re-infected with SARS-CoV-2. To date, no data are available on whether there is an unrecognized Covid-19 immunity in the population beyond the SARS-CoV-2 infections recorded. The Helmholtz Centre for Infection Research (HZI) in Braunschweig is now coordinating a study to investigate this question. Anonymous sera from more than 100,000 donors will be analyzed in the population study. The blood will be regularly tested for antibodies against the Covid-19 pathogen. The study will provide a more accurate picture of immunity and pandemic development.
27.03.2020
HZI Campus

HZI in the media

Mit Parkinson-Medikament zum Virulenzblocker gegen Krankenhauskeim

Quelle:

 

Pressemitteilung Helmholtz-Zentrum für Infektionsforschung HZI ...

10.12.2025
|
LaborPraxis
Parkinson-Medikament zeigt Wirkung gegen Krankenhauskeim: Saarbrücker Forschung entdeckt neuen Ansatz

Medikament Tolcapon identifiziert. Das HIPS ist ein Standort des Helmholtz-Zentrums für Infektionsforschung (HZI) in Kooperation ...

01.12.2025
|
Homburg
Kontinuität und frischer Wind: Neuer DZIF-Vorstand gewählt

... wissenschaftlicher Ko-Direktor des Helmholtz Zentrums für Infektionsforschung (HZI). Thomas Pietschmann engagiert sich seit 2023 im ...

28.11.2025
|
juraforum.de
Tolcapone & LecA: Blocking Bacterial Virulence Pathways

Dr. Alexander Titz, group leader at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS). “Finding new ways to disrupt its

28.11.2025
|
ARCHYDE
Kürzung von HIV-Programmen: Expertin warnt vor steigenden Fallzahlen

... “, sagte die Leiterin der Epidemiologie am Braunschweiger Helmholtz-Zentrum für Infektionsforschung.

 

Lange betonte, flächendeckende ...

28.11.2025
|
Evangelische Zeitung
Saarland: Saarland will Forschung stärker unterstützen und so Arbeitsplätze schaffen

... ein Zentrum für Quantentechnologie entstehen und das Helmholtz-Institut für Pharmazeutische Forschung ausgebaut werden.

 

Mehr ...

27.11.2025
|
Tagesschau
Barke: Halbe Milliarde Euro wird in Forschung investiert

Euro werden investiert in die Erweiterung des Helmholtz-Instituts für Pharmazeutische Forschung Saarland (HIPS). Und ...

27.11.2025
|
ZEIT online
Parkinson's drug tolcapone found to block key protein in hospital superbug

s drug tolcapone. HIPS is a site of the Helmholtz Center for Infection Research (HZI) in collaboration with Saarland University.

 

The

26.11.2025
|
Medical Xpress
„RNA Healer“ erhält rund eine Million Euro für Entwicklung von Leberfibrose-Therapie

... erhielt das Projekt „Citrapeutics“ vom Helmholtz-Zentrum für Infektionsforschung (HZI) in Braunschweig eine Förderung in Höhe ...

25.11.2025
|
Bionity.COM
Pattern of chronic rejection for liver transplants decoded

led by Hannover Medical School (MHH) and the Helmholtz Center for Infection Research (HZI) has now discovered clear molecular signatures for

24.11.2025
|
Medical Xpress
Lebertransplantation: Muster der chronischen Abstoßung entschlüsselt

Medizinischen Hochschule Hannover (MHH) und dem Helmholtz-Zentrum für Infektionsforschung (HZI), hat nun eindeutige molekulare Signaturen ...

24.11.2025
|
DeutschesGesundheitsPortal
HZI bringt Wissenschaft zum Anfassen in die Innenstadt

Braunschweig. Das Helmholtz-Zentrum für Infektionsforschung (HZI) bringt anlässlich seines 60. Jubiläums seine Forschung vom 3. ...

22.11.2025
|
Regional Heute

Register now for the HZI-Newsletter